1-5 of 5
Authors: Kandavadivu Umashankar
Save search
Sort by
Journal Article

Dose Escalation of Biologics in Biologic-Naïve Patients With Ulcerative Colitis: Outcomes From the ODESSA-UC Study

PDF
Sabyasachi Ghosh and others
Crohn's & Colitis 360, Volume 5, Issue 4, October 2023, otad061, https://doi.org/10.1093/crocol/otad061
Published: 16 November 2023
Journal Article

Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY

PDF
Noa Krugliak Cleveland and others
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1776–1787, https://doi.org/10.1093/ibd/izad245
Published: 31 October 2023
Journal Article

ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE RECEIVING DIFFERENT SEQUENCES OF FIRST- AND SECOND-LINE BIOLOGIC TREATMENTS: FINDINGS FROM ROTARY

PDF
Noa Cleveland and others
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S7–S8, https://doi.org/10.1093/ibd/izac015.013
Published: 22 January 2022
Journal Article

DOSE ESCALATION OF BIOLOGIC THERAPIES IN BIOLOGIC TREATMENT-NAÏVE ADULT PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE ODESSA DATABASE STUDY

PDF
Niranjan Kathe and others
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S9–S10, https://doi.org/10.1093/ibd/izac015.015
Published: 22 January 2022
Journal Article

ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING DIFFERENT SEQUENCES OF FIRST- AND SECOND-LINE BIOLOGIC TREATMENTS: FINDINGS FROM ROTARY

PDF
Noa Cleveland and others
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S8–S9, https://doi.org/10.1093/ibd/izac015.014
Published: 22 January 2022